Abstract
Resume. Lithium ascorbate is a highly digestible and low-toxic lithium salt. In stis study patients with stenosing arteriosclerosis of brachiocephalic arteries were under observation (n = 70, mean age 52 years, 50 % men). In group A (n = 30), participants received standard therapy and lithium ascorbate (0.78 mg/day of elemental lithium, 8 weeks), in group B (n = 40, control) - only the standard therapy. Effects of the lithium ascorbate on the results of neuropsychological testing (Luria's technique, Schulte tables, MMSE and BDI scales, visual-spatial gnosis), levels of BDNF and the levels of trace elements in hair have been established. Lithium ascorbate contributed to a significant improvement in work capacity, mood, a decrease in the proportion of patients with 20 % cerebral stenosis, increased levels of BDNF and a decrease in the levels of toxic trace elements in the hair.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Фармакокинетика и фармакодинамика
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
